 The purpose of this study is to see if the Artificial Pancreas AP Platform can successfully control blood sugar in people with type 1 diabetes mellitus on insulin pump therapy in a hospital setting. Investigators will also be studying to see if the heart rate informed Control To Range hrCTR can improve the performance of the system during and immediately after exercise. 